Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Mavacamten: Initial Insights From the Risk Evaluation and Mitigation Strategy Program.
Journal: JACC. Advances
Published: December 30, 2024
Mavacamten: Real-World Experience From 22 Months of the Risk Evaluation and Mitigation Strategy (REMS) Program.
Journal: Circulation. Heart failure
Published: November 11, 2024
Diverse Concepts in Definitions of Dilated Cardiomyopathy: Theory and Practice.
Journal: Cardiology research
Published: July 05, 2024
The role of early-phase trials and real-world evidence in drug development.
Journal: Nature cardiovascular research
Published: September 28, 2023
Response to "Critical Analysis of Apixaban Dose Adjustment Criteria".
Journal: Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
Published: May 23, 2022
Development of the sodium-glucose co-transporter 2 inhibitor dapagliflozin for the treatment of patients with type 2 diabetes mellitus.
Journal: Expert review of clinical pharmacology
Published: November 25, 2011
Showing 1-8 of 8
Last Updated: 09/26/2026